Medicines Stewardship
15 Apr 2025
WVA Position Statement on Availability of Veterinary Pharmaceuticals
Veterinary pharmaceuticals must be manufactured under strict guidelines and be licensed or registered and approved for use only after undergoing a rigorous quality assurance assessment that is regulated and evaluated by national or regional authorities. Additionally, legislation to authorize such regulation should be based on scientific evidence obtained through studies conducted by qualified veterinarians and scientists. Such regulatory measures will help ensure that veterinary pharmaceuticals, when used in accordance with the approved product label, will have minimal harmful or unintended effects on animals, people, or the environment.
Medicines Stewardship
15 Apr 2025
WVA Position Statement on Strengthening Veterinary Medicinal Products Regulation in Low and Middle-Income Countries
The World Veterinary Association (WVA) recognizes the indispensable role that veterinary pharmaceuticals (VP) and veterinary medical products (VMP) play in safeguarding animal health and welfare, enhancing sustainable livestock production, and supporting livelihoods in low and middle-income countries (LMIC). To sustain the benefits of VP and VMP, LMIC should strive to ensure progressive improvement in their technical capabilities to regulate VP and VMP effectively, thereby ensuring their quality, efficacy, and safety.
Medicines Stewardship
28 Dec 2024
WVA Position Statement on Responsible Use of Antimicrobials
Antimicrobials play a crucial role in maintaining animal health and welfare. However, their use can lead to the development of antimicrobial resistance (AMR), posing significant threats to both animal and human health. In response to this pressing issue, the WVA advocates for responsible antimicrobial use guided by risk-benefit analysis, veterinary oversight, regulatory control, and ongoing […]
Medicines Stewardship
25 Aug 2023
WVA Position Statement In Opposition To International Scheduling Of Ketamine
The World Veterinary Association (WVA) strongly objects to international control of ketamine, as this could lead to ketamine being no longer available to veterinary and medical practitioners for clinical use..
Medicines Stewardship
22 Sep 2020
List of Available Guidelines for Responsible use of Antimicrobials in Animal Health – Revision 6 – September 2020
The growing emergence of resistance to antimicrobials is a threat to humans, animals and the environment. This is an increasing global concern and many countries around the world have already taken measures to tackle the development of Antimicrobial Resistance (AMR).
Medicines Stewardship
14 Mar 2019
WVA Position Statement on Availability of Veterinary Pharmaceuticals
Veterinary pharmaceuticals must be manufactured under strict guidelines and be licensed or registered and approved for use only after undergoing a rigorous quality assurance assessment that is regulated and evaluated by national or regional authorities.
Medicines Stewardship
15 Nov 2018
WVA Position Statement on Animal Vaccination for Advancing Animal and Human Health
The WVA supports promoting the value of vaccinating animals to reduce the risk of infectious and zoonotic diseases by developing educational materials for use by veterinarians to increase client education surrounding appropriate vaccination programs, and collaborating with other health professions to ensure sufficient resources to advance scientific understanding of vaccine pharmacology and immunology.
Medicines Stewardship
31 Aug 2015
Pharmaceutical Stewardship” – A Strategic Priority for the World Veterinary Association
Association held its strategic planning session in March of 2015, we identified pharmaceutical stewardship as one of five major priority issues for (at least) the next three years.